The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy of epirubicin-paclitaxel (EPI-TAX) prior to high-dose chemotherapy (HDCT) in germ cell tumors (GCTs): A 17-year experience.
 
Jean-Pierre Lotz
No Relationships to Disclose
 
Daniele Grazziotin Soares
No Relationships to Disclose
 
Stephane Culine
Consulting or Advisory Role - Janssen; Roche
Research Funding - Astellas Oncology; MSD; Roche
Travel, Accommodations, Expenses - Amgen; Astellas Oncology; Janssen
 
Benjamin Laverdant
No Relationships to Disclose
 
Anne Kieffer
No Relationships to Disclose
 
Yohann Dabi
No Relationships to Disclose
 
Joseph Gligorov
No Relationships to Disclose
 
Frederic Selle
Honoraria - PharmaMar; Roche
Consulting or Advisory Role - PharmaMar; Roche
Travel, Accommodations, Expenses - AstraZeneca; PharmaMar; Roche